Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
February 2002
Features
Drug Shortages (4-Part Series)
Part 1: Antimicrobial Shortages
In the first article in this four-part series, Dr. Babinchak discusses the scope and consequences of antimicrobial shortages.
Timothy J. Babinchak, MD
Pharmaceutical-Approval Update
New treatments for gram-positive and gram-negative bacteria, rheumatoid arthritis, and migraine, along with a new antiviral drug for the treatment of HIV-1 infection.
Marvin M. Goldenberg, PhD
Continuing Education Credit
Oral Anticonvulsants Used in the Chronic Management of Seizure Disorders
The author provides an overview of anticonvulsants approved during the past 25 years for the treatment and
management of seizures.
Gale M. Tucker, PharmD, RPh
Departments
Editorial
Beyond Bar Codes: FindtheDOT
David B. Nash, MD, MBA, Editor-in-Chief,
goes beyond bar codes to “FindtheDOT.”
David B. Nash, MD, MBA
Drug News
New Drugs/Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.
Prescription Washington
Pharmaceutical “Rules of Engagement”
Stephen Barlas discusses the forthcoming
pharmaceutical “Rules of Engagement.”
Stephen Barlas
Drug Forecast
Review of Almotriptan: A 5-HT1B/1D Agonist
Review of Almotriptan: A 5-HT1B/1D agonist for the treatment of migraine.
Brooke D. Fidler, PharmD
Medication Errors
Medication Error or Professional Judgement?
Matthew Grissinger, RPh, discusses the question
of who is to blame for “omission errors.”
Matthew Grissinger, RPh
